Skip to main content
. 2014 Sep 23;2:124. doi: 10.3389/fpubh.2014.00124

Table 1.

Description of selected characteristics of the study population and design by center as of December 2013.

Study center Study region Diagnostic period
Number of participating hospitals
No. of ethics committees (e.g., IRBs) needed to obtain ethics for all participating hospitals Direct access to data on eligible patients periodically or in the end of the study Expected number of eligible cases
Start End Cases Controls Target population at risk Expected eligible cases (per year)
Australia Greater metropolitan areas of Melbourne and Sydney June 2012 December 2014 10 26 25 No 1,600,000 32
Austria Nationwide June 2012 December 2014 4 7 10 Yes 1,500,000 30
Canada Greater metropolitan areas of Ottawa, Toronto, and Vancouver June 2012 December 2014 7 12 15 Yes 1,760,905 54
France 15 Districts in 7 areas: Lorraine, Ile-de-France, Rhône-Isère, Hérault, Bouches-du-Rhône, Alsace, Gironde March 2011 December 2014 14 44 1 Yes 3,485,577 63
Germany Nationwide October 2010 June 2014 62 65 8 No 5,598,131 84
Greece Nationwide May 2010 December 2013 23 19 16a No 1,690,000 16
India Mumbai May 2013 December 2014 2 2 2 Yes 4,358,085 28
Israel Nationwide August 2010 December 2014 5 10 10 Yes 1,800,000 27
Italy Four regions: Piemonte, Lombardia, Toscana, and Emilia Romagna January 2011 September 2014 33 39 45 Yes 2,937,400 46
Japan Tokyo metropolitan area June 2011 December 2014 18 13 23 No 1,700,000 34
Korea Metropolitan areas of Seoul and Incheon and Gyeonggi-do province January 2012 December 2014 5 10 8 No 4,713,814 52
New Zealand Nationwide June 2013 December 2014 Yes 925,720 17
Spain Four autonomous communities: Andalucia, Catalonia, Madrid, and Valencia January 2011 December 2014 58 69 69 Yes 4,134,986 43
The Netherlands Nationwide June 2011 December 2014 10 7 17 No 1,600,000 30
Total May 2010 December 2014 251 323 249 37,804,618 556